- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02903875
Therapeutic Education Program for Laryngectomised Patients and Their Close Relations (PETAL)
Therapeutic Education Program Aimed at Improving the Quality of Life of Laryngectomised Patients and Their Close Relatives
The therapeutic education of patients and their close relations is, as yet, poorly developed in France in the field of oncology, in particular for cancers of the upper aerodigestive tract. In the case of pharyngeal and laryngeal cancer, total laryngectomy associated with radiotherapy remains a reference treatment for advanced stage cancers. This mutilating surgical procedure has a major impact on the patient's life, due to its physical and functional sequelae. Its psychosocial consequences are also important, owing to the biographical disruption and the identity-related metamorphoses associated with illness and its treatment, which alter the quality of life not only of patients, but also of their close relations. Currently, care for laryngectomised patients consists essentially in informing and educating them on certain technical procedures during hospital admission. New voice education can be a long process and often involves the intervention of a speech therapist, who serves as the link between the patient and the hospital care team. These healthcare modalities often insufficiently account for the social, environmental and personal factors that interact in health-related problems.
The aim is to design, implement and evaluate a patient therapeutic education (PTE) programme, for laryngectomised patients and their close relations, aimed at improving their quality of life.
The research will be conducted over three phases:
The first phase, referred to as the "pilot" phase, will include exploratory, observational and retrospective analysis aimed at developing knowledge on the consequences of laryngectomy on the quality of life of patients and their close relations, the strengths and weaknesses of current practice in patient support and the needs expressed by the players involved (patients, relations, professional carers). This analysis will be conducted via interviews with patients and their close relations and focus groups with the healthcare professionals involved in patient care and support (hospital and independent). This first phase will enable the pluridisciplinary design of a therapeutic education programme for laryngectomised patients and their close relations which will be tested in the study's principle coordinating centre. The method defined thus is in keeping with quality criteria set by the HAS specifying that the PTE should focus on the patient, be scientifically justified, and be developed by a pluridisciplinary group reuniting representatives of patients or patient associations.
The second phase, referred to as the prospective intervention "replication" phase, aims at evaluating the programme's transferability and quality in three centres. The centres participating in this second phase already have experience in the development of PTE programmes and will be involved in the workgroup entrusted with the design of the PETAL programme during phase 1.
The third phase, referred to as the "randomised" multicentric comparative intervention phase, should enable us to assess the benefits of the developed PTE programme on the quality of life of patients and their close relations.
This is a pluridisciplinary study via which we hope to improve the quality of life of laryngectomised patients and their close relations through the design and the sustainable deployment of an innovative PTE programme in France and Belgium. This project also aims at reinforcing town-hospital links to improve help, follow-up and support for patients and their close relations, as well as dialogue between healthcare professionals.
Study Overview
Status
Conditions
Intervention / Treatment
Study Type
Enrollment (Anticipated)
Contacts and Locations
Study Locations
-
-
-
Caen, France
- CAEN university Hospital
-
Caen, France
- Caen Cancer Institute
-
Lille, France
- Lille University Hospital
-
Lille, France
- Lille Cancer Institute
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Sampling Method
Study Population
Description
Inclusion Criteria:
- Patient (18-70 years) treated with total laryngectomy for cancer of the larynx, pharynx or cervical esophagus
- Patient agreeing to participate in the study (informed consent)
- Person designated as close relative by the laryngectoised patient (support person, spouse, parent, caregiver)
- Close relative agreeing to participate in the study (informed consent) after the patient himself has authorized the investigator to contact that person to offer to participate in the study
- Time since laryngectomy (group 1 : 1 month, group 2: 3 months, group 3: 6 months, group 4 : 12 months)
Exclusion Criteria:
- Physical , mental, cognitive or psychiatric disabilityof the patient to answer questions and participate in interviews and therapeutic education program
- Physical , mental, psychiatric or cognitive disability of the close relative to answer questions and participate in interviews and therapeutic education program
Study Plan
How is the study designed?
Design Details
Cohorts and Interventions
Group / Cohort |
Intervention / Treatment |
---|---|
laryngectomised patients since 1 month
laryngectomised patients since 1 month and their close relative
|
|
laryngectomised patients since 3 months
laryngectomised patients since 3 months and their close relative
|
|
laryngectomised patients since 6 months
laryngectomised patients since 6 months and their close relative
|
|
laryngectomised patients since 12 months
laryngectomised patients since 12 months and their close relative
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
interview of patient and close relatives
Time Frame: baseline
|
design, implement and evaluate a patient therapeutic education (PTE) programme, for laryngectomised patients and their close relations, aimed at improving their quality of life.
|
baseline
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
transferability of patient therapeutic education (PTE)
Time Frame: during 1 year
|
evaluating the programme's transferability in three centres
|
during 1 year
|
quality of patient therapeutic education (PTE)
Time Frame: during 1 year
|
evaluating the programme's quality in three centres
|
during 1 year
|
quality of life (QLQC30)
Time Frame: baseline and 1 year after PTE
|
to assess the benefits of the developed PTE programme on the quality of life of patients and their close relations
|
baseline and 1 year after PTE
|
Collaborators and Investigators
Study record dates
Study Major Dates
Study Start
Primary Completion (Anticipated)
Study Completion (Anticipated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimate)
Study Record Updates
Last Update Posted (Estimate)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- PHRC12-220
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Head and Neck Cancer
-
Robert FerrisAmgenCompletedHead and Neck Cancer | Cancer of Head and Neck | Head Cancer | Neck Cancer | Neoplasms, Head and Neck | Cancer of the Head and Neck | Cancer of Neck | Upper Aerodigestive Tract Neoplasms | Neck Neoplasms | Cancer of the Head | Cancer of the Neck | UADT Neoplasms | Cancer of Head | Head Neoplasms | Head, Neck Neoplasms | Neoplasms, Head and other conditionsUnited States
-
Assiut UniversityRecruitingHead and Neck Cancer | Head and Neck Neoplasms | Cancer of Head and Neck | Neoplasms, Head and Neck | Cancer of the Head and NeckEgypt
-
Mayo ClinicRecruitingCancer Head Neck | Cancer Neck | Cancer, HeadUnited States
-
IRCCS Policlinico S. MatteoNestlé Health Science Spain; Akern SrlCompletedHead-neck CancerItaly
-
University of California, San FranciscoCompleted
-
Chinook Therapeutics, Inc. (formerly Aduro)TerminatedRecurrent Head and Neck Cancer | Metastatic Head and Neck CancerUnited States
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)TerminatedHead And Neck CancerUnited States
-
National Cancer Institute (NCI)TerminatedRecurrent Head and Neck Cancer | Metastatic Head and Neck CancerUnited States
-
Radboud University Medical CenterUnknown
-
Centre Oscar LambretUnknownEpidermoid Head and Neck CancerFrance
Clinical Trials on Patient therapeutic education (PTE) programme
-
Lund UniversityRegion Skåne, Primary health care, SwedenCompletedOsteoarthritis in the Hip, Knee and HandSweden
-
University Hospital, ToulouseCompleted
-
Odense University HospitalCompletedQuality of Life | Osteoporosis | Behavior | Level of AdherenceDenmark
-
Institut National de la Santé Et de la Recherche...Regional Agency for Health PACA; SESSTIM UMR1252 (Aix-Marseille Univ, INSERM...CompletedAlcohol Use DisorderFrance
-
Barts & The London NHS TrustAsthma UK; Social Action for Health; Department of Health (Service Support); Noreen...Completed
-
University Hospital, ToulouseCompleted
-
University Hospital, GenevaBayer; AstraZeneca; Vifor Pharma; Labatec Pharma SATerminatedMedication Adherence | Knowledge, Attitudes, Practice | Heart Failure With Reduced Ejection Fraction | Pharmacist-Patient Relations | Heart Failure; With DecompensationSwitzerland
-
Stefania La Grutta, MDCompleted
-
Ain Shams UniversityActive, not recruiting
-
University Hospital, MontpellierAssociation Francaise pour la Recherche ThermaleCompletedPrevention of FallsFrance